pioglitazone has been researched along with Scleroderma, Localized in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Scleroderma, Localized: A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques (morphea), bands (linear), or nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There are only a few studies on the treatment of dermal fibrosis with sustained-release drugs." | 5.51 | Nanoparticle-mediated local delivery of pioglitazone attenuates bleomycin-induced skin fibrosis. ( Arita, T; Asai, J; Jo, JI; Kanemaru, M; Katoh, N; Kawai-Ohnishi, M; Tabata, Y; Tsutsumi, M; Wada, M, 2019) |
| "There are only a few studies on the treatment of dermal fibrosis with sustained-release drugs." | 1.51 | Nanoparticle-mediated local delivery of pioglitazone attenuates bleomycin-induced skin fibrosis. ( Arita, T; Asai, J; Jo, JI; Kanemaru, M; Katoh, N; Kawai-Ohnishi, M; Tabata, Y; Tsutsumi, M; Wada, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanemaru, M | 1 |
| Asai, J | 1 |
| Jo, JI | 1 |
| Arita, T | 1 |
| Kawai-Ohnishi, M | 1 |
| Tsutsumi, M | 1 |
| Wada, M | 1 |
| Tabata, Y | 1 |
| Katoh, N | 1 |
1 other study available for pioglitazone and Scleroderma, Localized
| Article | Year |
|---|---|
Nanoparticle-mediated local delivery of pioglitazone attenuates bleomycin-induced skin fibrosis.
Topics: Animals; Bleomycin; Cell Differentiation; Delayed-Action Preparations; Disease Models, Animal; Drug | 2019 |